Levilactobacillus brevis NSMJ23的完整基因组序列,具有抗菌活性的makgeolli分离物
Ju-Hyung Jeon1, Jun Sung Kim1, Z-Hun Kim2
1Microbial Research Department, Nakdonggang National Institute of Biological Resources (NNIBR), Sangju-si, Gyeongsangbuk-do, South Korea.
Microbiology resource announcements
|January 5, 2024
概括
我们测序了益生菌 *Levilactobacillus brevis* NSMJ23.3 的基因组. 这为了解其有益的特性和在健康和营养方面的潜在应用提供了基础资源.
科学领域:
- 微生物学 微生物学
- 基因组学就是基因组学.
- 益生菌 益生菌是一种益生菌.
背景情况:
- 益生菌是一种有益的微生物,用于促进健康.
- 莱维拉克托巴西勒斯 (Levilactobacillus brevis) 是一种以其益生菌潜力而闻名的物种.
- 在基因组层面描述益生菌菌株对于理解它们的机制至关重要.
研究的目的:
- 报告 *Levilactobacillus brevis* NSMJ23.23 的完整基因组序列.
- 为益生菌细菌菌株提供基因组资源.
- 为了促进进一步研究这种菌株的益生菌性质.
主要方法:
- *Levilactobacillus brevis*的全基因组测序 NSMJ23.3. 这是一个很好的方法.
- 用于基因组组装和基因预测的生物信息分析.
- 基因组特征的表征,例如染色体和等离子体含量.
主要成果:
- 确定了 *Levilactobacillus brevis* NSMJ23 的完整基因组序列.
- 该基因组包括2,389,998-bp染色体和七个质粒.
- 总共有2624个基因被确定,包括2457个蛋白质编码序列,GC含量为45.59%.
结论:
- 获得Levilactobacillus brevis* NSMJ23的完整基因组序列是一个重要的进步.
- 这些基因组数据将有助于阐明其益生菌功能的遗传基础.
- 这些发现支持继续研究和应用*L. brevis* NSMJ23作为益生菌剂.
相关概念视频
00:57Antibiotic Selection
Overview
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...